Skip to main content
SpringerLink
Log in

Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status

  • Papers
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Autologous bone marrow and peripheral blood stem cell transplants permit the use of higher doses of chemoradiotherapy than would have been possible without ‘rescuing’ bone marrow function. This may well allow cure of malignant disorders in cases where this was previously not feasible. This short review attempts to summarize the current status of such a treatment approach for the various haematological malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McGovern, J., Russell, P. and Atkins Webster, E.W. (1959) Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission.N. Engl. J. Med. 260, 675–83.

    PubMed  Google Scholar 

  2. McFarland, W., Granville, N.B. and Dameshek, W. (1959) Autologous bone marrow infusion as an adjunct in therapy of malignant disease.Blood 14, 503–21.

    PubMed  CAS  Google Scholar 

  3. Clifford, P., Clift, R.A. and Duff, J.K. (1961) Nitrogen-mustard therapy combined with autologous marrow infusion.Lancet 1, 687–90.

    Article  PubMed  CAS  Google Scholar 

  4. Buckner, C.D., Clift, R.A., Fefer, A., Neiman, P.E., Storb, R. and Thomas, E.D. (1974) Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclo-phosphamide, total body irradiation and infusion of cryo-preserved autologous marrow.Exp. Hematol. 2, 138–46.

    PubMed  CAS  Google Scholar 

  5. Goldman, J.M., Catovsky, D. and Galton, D.A.G. (1978) Reversal of blast-cell crisis in C.G.L. by transfusion of stored autologous buffy-coat cells.Lancet 1, 437–8.

    Article  PubMed  CAS  Google Scholar 

  6. Körbling, M., Burke, P., Braine, H., Elfenbein, G., Santos, G. and Kaizer, H. (1981) Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia.Exp. Hematol. 9, 684–90.

    PubMed  Google Scholar 

  7. Mehta, J., Powles, R.L., Shepherd, V., Dainton, M. and Treleaven, J. (1993) Transplantation of autologous peripheral blood stem cells mobilized using GM-CSF for acute leukemia with myelofibrosis.Leuk. Lymphoma 11, 157–8.

    Article  PubMed  CAS  Google Scholar 

  8. Kessinger, A., Vose, J.M., Bierman, P.J. and Armitage, J.O. (1991) High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metas-tases and relapsed lymphoma: an alternative to bone marrow purging.Exp. Hematol. 19, 1013–16.

    PubMed  CAS  Google Scholar 

  9. To, L.B., Roberts, M.M., Haylock, D.N.et al (1992) Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.Bone Marrow Transplant. 9, 277–84.

    PubMed  CAS  Google Scholar 

  10. Peters, W.P., Rosner, G., Ross, M.et al (1993) Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy.Blood 81, 1709–19.

    PubMed  CAS  Google Scholar 

  11. Talpaz, M. and Spitzer, G. (1984) Low natural killer cell activity in the bone marrow of healthy donors with normal natural killer cell activity in the peripheral blood.Exp. Hematol. 12, 629–32.

    PubMed  CAS  Google Scholar 

  12. Roberts, M.M., To, L.B., Gillis, D.et al. (1993) Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation.Bone Marrow Transplant. 12, 469–75.

    PubMed  CAS  Google Scholar 

  13. Mehta, J., Powles, R., Singhal, S. and Treleaven, J. (1995) Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells.Bone Marrow Transplant. 15, 652–3.

    PubMed  CAS  Google Scholar 

  14. Körbling, M., Fliedner, T.M., Holle, R.et al. (1991) Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival.Bone Marrow Transplant. 7, 343–9.

    PubMed  Google Scholar 

  15. Gribben, J.G., Neuberg, D., Barber, M.et al. (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow.Blood 83, 3800–07.

    PubMed  CAS  Google Scholar 

  16. Corradini, P., Voena, C., Astolh, M.et al. (1995) High-dose sequential chemoradiotherapy in multiple myeloma: Residual rumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.Blood 85, 1596–1602.

    PubMed  CAS  Google Scholar 

  17. Liberti, G., Pearce, R., Taghipour, G., Majolino, I. and Goldstone, A.H. (1994) Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data.Ann. Oncol. 5 (Suppl. 2), S151–53.

    Google Scholar 

  18. Hutchinson, R.M., Bell, A.J., Duguid, J.K.M.et al (1994) Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation.Transfus. Med. 4, 165–72.

    Article  Google Scholar 

  19. Mehta, J., Powles, R., Cabral, S.et al. (1995) Comparison of Cobe Spectra and Haemonetics MCS-3P cell separators for harvesting peripheral blood stem cells.Bone Marrow Transplant, (accepted for publication).

  20. Shimazaki, C., Oku, N., Ashihara, E.et al. (1992) Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.Bone Marrow Transplant. 10, 341–6.

    PubMed  CAS  Google Scholar 

  21. Pettengell, R., Morgenstern, G.R., Woll, P.J.et al. (1993) Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.Blood 82, 3770–7.

    PubMed  CAS  Google Scholar 

  22. Bensinger, W., Singer, J., Appelbaum, F.et al. (1993) Autologous transplantation with peripheral blood mono-nuclear cells collected after administration of recombinant granulocyte stimulating factor.Blood 81, 3158–63.

    PubMed  CAS  Google Scholar 

  23. Vadhan-Raj, S., Papadopoulos, N., Burgess, M., Patel, S., Linke, K., Plager, C., Hayes, C., Arcenas, A., Kudelka, A., Williams, D., Garrison, L. and Benjamin, R. (1993) Optimization of Dose and Schedule of PIXY 321 (GM-CSF/IL-3 Fusion Protein) to Alternate Chemotherapy Induced Multilineage Myelosuppression in Patients With Sarcomas [abstract 1640]Proc. Am. Soc. Clin. Oncol. 12, 470.

    Google Scholar 

  24. Schmitz, N., Dreger, P., Suttorp, M.et al. (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor).Blood 85, 1666–72.

    PubMed  CAS  Google Scholar 

  25. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R.et al. (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.Blood 85, 1655–8.

    PubMed  CAS  Google Scholar 

  26. Körbling, M., Przepiorka, D., Huh, Y.O.et al. (1995) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.Blood 85, 1659–65.

    PubMed  Google Scholar 

  27. Kîrbling, M., Hunstein, W., Fliedner, T.M.et al. (1989) Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.Blood 74, 1898–1904.

    Google Scholar 

  28. Linker, C.A., Ries, C.A., Damon, L.E., Rugo, H.S. and Wolf, J.L. (1993) Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.Blood 81, 311–8.

    PubMed  CAS  Google Scholar 

  29. Burnett, A.K., Tansey, P., Watkins, R.et al. (1984) Transplantation of unpurged autologous bone-marrow in acute myeloid leukaemia in first remission.Lancet 2, 1068–70.

    Article  PubMed  CAS  Google Scholar 

  30. Laporte, J.P., Douay, L., Lopez, M.et al. (1994) One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfa-mide: a 10-year single institution experience.Blood 84, 3810–8.

    PubMed  CAS  Google Scholar 

  31. Sanz, M.A., De la Rubia, J., Sanz, G.F.et al. (1993) Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myelo-blastic leukemia in first complete remission: a report from a single institution.J. Clin. Oncol. 11, 1661–7.

    PubMed  CAS  Google Scholar 

  32. Keating, A., Rowlings, P.A., Horowitz, M.M., Dicke, K., Gale, R.P. and Klein, J.P. (1994) Comparison of HLA-identical sibling and autologous bone marrow transplants for acute myelogenous leukemia (AML).Blood 84 (Suppl1), 201a.

    Google Scholar 

  33. Gorin, N.C., Labopin, M., Esperou-Bourdeau, H. and Gluckman, E. (1994) Comparison of allogeneic and autologous bone marrow transplantation for acute myelocytic leukemia (AML) in Europe. An EBMT survey.Blood 84 (Suppl 1), 211a.

    Google Scholar 

  34. Zittoun, R.A., Mandelli, F., Willemze, R.et al. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia.N. Engl J. Med. 332, 217–23.

    Article  PubMed  CAS  Google Scholar 

  35. De la Rubia, J., Sanz, G.F., Martinez, J.et al. (1994) Autologousblood stem cell transplantation in acute myeloblastic leukemia in first remission.Blood 84 (Suppl 1), 213a.

    Google Scholar 

  36. Petersen, F.B., Lynch, M.H.E., Clift, R.A.et al. (1993) Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.J. Clin. Oncol 11, 1353–60.

    PubMed  CAS  Google Scholar 

  37. Meloni, G., De Fabritiis, P., Petti, M.C. and Mandelli, F. (1990) BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission.Blood 75, 2282–5.

    PubMed  CAS  Google Scholar 

  38. Chopra, R., Goldstone, A.H., McMillan, A.K.et al. (1991) Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.J. Clin. Oncol. 9, 1840–7.

    PubMed  CAS  Google Scholar 

  39. Schiffman, K., Clift, R., Appelbaum, F.R.et al. (1993) Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.Bone Marrow Transplant. 11, 227–32.

    PubMed  CAS  Google Scholar 

  40. Fiäre, D., Lepage, E., Sebban, C.et al. (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy.J. Clin. Oncol 10, 1990–2001.

    Google Scholar 

  41. Doney, K., Buckner, C.D., Fisher, L.et al. (1993) Autologous bone marrow transplantation for acute lymphoblastic leukemia.Bone Marrow Transplant. 12, 315–21.

    PubMed  CAS  Google Scholar 

  42. Proctor, S.J., Hamilton P.J., Taylor, P.et al. (1988) A comparative study of combination chemotherapy versus marrow transplant in first remission in adult acute lymphoblastic leukaemia.Br. J. Haematol. 69, 35–9.

    Article  PubMed  CAS  Google Scholar 

  43. Vey, N., Blaise, D., Stoppa, A.M.et al. (1994) Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.Bone Marrow Transplant. 14, 383–8.

    PubMed  CAS  Google Scholar 

  44. Powles, R., Mehta, J., Singhal, S.et al. (1995) Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center.Bone Marrow Transplant. 16, 241–7.

    PubMed  CAS  Google Scholar 

  45. Fletcher, J.A., Lynch, E.A., Kimball, V.M., Donnelly, M., Tantravahi, R. and Sallan, S.E. (1991) Translation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.Blood 77, 435–9.

    PubMed  CAS  Google Scholar 

  46. Carella, A.M., Frassoni, F., Pollicardo, N.et al. (1995) Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia.Br. J. Haematol 89, 535–8.

    Article  PubMed  CAS  Google Scholar 

  47. Goto, T., Nishikori, M., Arlin, Z.et al. (1982) Growth characteristics of leukemic and normal hematopoietic cells in Ph’ + chronic myelogenous leukemia and effects of intensive treatment.Blood 59, 793–808.

    PubMed  CAS  Google Scholar 

  48. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.N. Engl J. Med. 330, 820–5.

    Article  Google Scholar 

  49. McGlave, P.B., De Fabritiis, P., Deisseroth, A.et al. (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups.Lancet 343, 1486–8.

    Article  PubMed  CAS  Google Scholar 

  50. Barnett, M.J., Eaves, C.J., Phillips, G.L.et al. (1994) Auto-grafting with cultured marrow in chronic myeloid leukemia: results of a pilot study.Blood 84, 724–32.

    PubMed  CAS  Google Scholar 

  51. Carella, A.M., Pollicardo, N., Pungolino, E.et al. (1993) Mobilization of cytogenetically ‘normal’ blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia.Leuk. Lymphoma 9, 477–83.

    Article  PubMed  CAS  Google Scholar 

  52. Kuss, B.J., Sage, R.E., Shepherd, K.M., Hardingham, J. and Nicola, M. (1993) High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukaemia.Leuk. Lymphoma 10, 73–8.

    Article  PubMed  CAS  Google Scholar 

  53. Kantarjian, H.M., Talpaz, M., Hester, J.et al. (1995) Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy.J. Clin. Oncol. 13, 553–9.

    PubMed  CAS  Google Scholar 

  54. Rabinowe, S.N., Soiffer, R.J., Gribben, J.G.et al. (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia.Blood 82, 1366–76.

    PubMed  CAS  Google Scholar 

  55. Khouri, I.F., Keating, M.J., Vriesendorp, H.M.et al. (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results.J. Clin. Oncol. 12, 748–58.

    PubMed  CAS  Google Scholar 

  56. Bastion, Y., Felman, P., Dumontet, C., Espinouse, D. and Coiffier, B. (1992) Intensive radio chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia.Bone Marrow Transplant. 10, 467–8.

    PubMed  CAS  Google Scholar 

  57. Bartlett-Pandite, L., Soiffer, R., Gribben, J.G.et al. (1994) Autologous and allogeneic bone marrow transplantation for B-cell CLL: balance between toxicity and efficacy.Blood 84 (Suppl 1), 536a.

    Google Scholar 

  58. Zomas, A., Mehta, J., Powles, R.et al. (1994) Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.Bone Marrow Transplant. 14, 799–803.

    PubMed  CAS  Google Scholar 

  59. McElwain, T.J., and Powles, R.L. (1983) High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.Lancet 2, 822–4.

    Article  PubMed  CAS  Google Scholar 

  60. Singhal, S., Powles, R., Cunningham, D. et al. (1995) Clearance of paraprotein after autografting for multiple myeloma.Bone Marrow Transplant. 16, (in press).

  61. Reece, D.E., Barnett, M.J., Connors, J.M.et al (1993) Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.Bone Marrow Transplant. 11, 139–46.

    PubMed  CAS  Google Scholar 

  62. Schiller, G., Vescio, R., Freytes, C.et al. (1995) Transplantation of CD34 + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced myeloma.Blood 86, 390–7.

    PubMed  CAS  Google Scholar 

  63. Cunningham, D., Paz-Ares, L., Milan, S.et al. (1994) High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.J. Clin. Oncol. 12, 759–63.

    PubMed  CAS  Google Scholar 

  64. Anderson, K.C., Barut, B.A., Ritz, J.,et al. (1991) Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.Blood 77, 712–20.

    PubMed  CAS  Google Scholar 

  65. Bjîrkstrand, B., Ljungman, P., Bird, J.M., Samson, D. and Gahrton, G. (1995) Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.Bone Marrow Transplant. 15, 367–71.

    Google Scholar 

  66. Dimopoulos, M.A., Alexanian, R., Przepiorka, D.et al. (1993) Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma.Blood 82, 2324–8.

    PubMed  CAS  Google Scholar 

  67. Harousseau, J.L., Attal, M., Divine, M.et al. (1995) Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.Bone Marrow Transplant. 15, 963–9.

    PubMed  CAS  Google Scholar 

  68. Jagannath, S., Vesole, D.H., Glenn, J., Crowley, J. and Barlogie, B. (1992) Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support.Blood 80, 1666–72.

    PubMed  CAS  Google Scholar 

  69. Barlogie, B., Jagannath, S., Vesole, D.et al. (1994) Total therapy (TT) for 202 newly diagnosed patients (pts) with multiple myeloma (MM).Blood 84 (Suppl 1), 386a.

    Google Scholar 

  70. Powles, R., Cunningham, D., Malpas, J.S.et al. (1994) A randomised trial of maintenance therapy with Intron-A following high-dose melphalan and ABMT in myeloma.Blood 84 (Suppl 1), 535a.

    Google Scholar 

  71. Cunningham, D., Powles, R., Malpas, J.et al (1995) A randomised trial of maintenance interferon following high dose chemotherapy in multiple myeloma (manuscript in preparation).

  72. Chopra, R., McMillan, A.K., Linch, D.C.et al. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin’s disease. A single-center eight-year study of 155 patients.Blood 81, 1137–45.

    PubMed  CAS  Google Scholar 

  73. Reece, D.E., Connors, J.M., Spinelli, J.J.et al. (1994) In- tensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin’s disease in first relapse after combination chemotherapy.Blood 83, 1193–9.

    PubMed  CAS  Google Scholar 

  74. Anderson, J.E., Litzow, M.R., Appelbaum, F.R.et al. (1993) Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin’s disease: the 21-year Seattle experience.J. Clin. Oncol. 11, 2342–50.

    PubMed  CAS  Google Scholar 

  75. Carella, A.M., Carlier, P., Congiu, A.et al. (1991) Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin’s disease in first complete remission after MOPP/ABVD protocol.Bone Marrow Transplant. 8, 99–103.

    PubMed  CAS  Google Scholar 

  76. Mills, W., Chopra, R., McMillan, A., Pearce, R., Linch, D.C. and Goldstone, A.H. (1995) BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non Hodgkin’s lymphoma.J. Clin. Oncol. 13, 588–95.

    PubMed  CAS  Google Scholar 

  77. Rapoport, A.P., Rowe, J.M., Kouides, P.A.et al. (1993) One hundred autotransplants for relapsed or refractory Hodgkin’s disease and lymphoma: value of pretransplant disease status for predicting outcome.J. Clin. Oncol. 11, 2351–61.

    PubMed  CAS  Google Scholar 

  78. Wheeler, C., Strawderman, M., Ayash, L.et al. (1993) Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin’s lymphoma with cyclophosphamide, carmustine, and etoposide.J. Clin. Oncol. 11, 1085–91.

    PubMed  CAS  Google Scholar 

  79. Haioun, C., Lepage, E., Gisselbrecht, C.et al. (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin’s lymphoma in first complete remission: a study of 464 patients.J. Clin. Oncol. 12, 2543–51.

    PubMed  CAS  Google Scholar 

  80. Verdonck, L.F., van Putten, W.L., Hagenbeek, A.et al. (1995) Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin’s lymphoma.N. Engl. J. Med. 332, 1045–51.

    Article  PubMed  CAS  Google Scholar 

  81. Philip, T., Guglielmi, C, Hagenbeek, A.et al. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma.New Engl. J. Med. 333, 1540–5.

    Article  PubMed  CAS  Google Scholar 

  82. Miller, J.S., Arthur, D.C, Litz, C.E., Neglia, J.P., Miller, W.J. and Weisdorf, D.J. (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy.Blood 83, 3780–6.

    PubMed  CAS  Google Scholar 

  83. Talbot, D.C, Powles, R.L., Sloane, J.P.et al. (1990) Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.Bone Marrow Transplant. 6, 17–20.

    PubMed  CAS  Google Scholar 

  84. Rizzoli, V., Carella, A.M., Carlo-Stella, C. and Mangoni, L. (1990) Autologous marrow transplantation in acute lym-phoblastic leukemia: control of residual disease with ma-fosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.Bone Marrow Transplant. 6 Suppl. 1, 76–8.

    PubMed  Google Scholar 

  85. Carella, A.M., Gaozza, E., Raffo, M.R.et al. (1991) Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autorransplant and cyclosporine A.Leukemia 5, 517–21.

    PubMed  CAS  Google Scholar 

  86. Yeager, A.M., Vogelsang, G.B., Jones, R.J.et al. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.Blood 79, 3031–5.

    PubMed  CAS  Google Scholar 

  87. Morecki, S., Revel Vilk, S., Nabet, C.et al. (1992) Immuno-logical evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.Cancer Immunol. Immunother. 35, 401–11.

    Article  PubMed  CAS  Google Scholar 

  88. Nagler, A., Ackerstein, A., Or, R.et al. (1992) Adoptive immunotherapy with mismatched allogeneic peripheral blood lymphocytes (PBL) following autologous bone marrow transplantation (ABMT).Exp. Hematol. 20, 705.

    Google Scholar 

  89. Benyunes, M.C., Massumoto, C., York, A.et al. (1993) Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia.Bone Marrow Transplant. 12, 159–63.

    PubMed  CAS  Google Scholar 

  90. Rowe, J.M., Ryan, D.H., Nilsson, B.I.et al. (1994) Chronic myelogenous leukemia treated with autologous bone marrow transplantation followed by roquinimex.Blood 84 (Suppl 1), 204a.

    Google Scholar 

  91. Neubauer, M.A., Benyunes, M.C, Thompson, J.A.et al. (1994) Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 13, 311–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haematology/Oncology Centre, Nicosia, Cyprus

    George Marcoullis

  2. Leukaemia and Myeloma Units, Royal Marsden Hospital, Surrey, UK

    Jayesh Mehta & Jennie Treleaven

Authors
  1. George Marcoullis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jayesh Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennie Treleaven
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marcoullis, G., Mehta, J. & Treleaven, J. Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status. Med Oncol 12, 209–218 (1995). https://doi.org/10.1007/BF02990566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990566

Keywords

Search

Navigation